| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.32B | 44.28B | 38.42B | 35.38B | 30.41B | 25.21B |
| Gross Profit | 12.73B | 13.72B | 11.66B | 9.04B | 6.59B | 5.84B |
| EBITDA | 14.53B | 15.04B | 13.85B | 10.41B | 8.09B | 6.59B |
| Net Income | 8.71B | 8.82B | 8.75B | 6.81B | 4.75B | 4.31B |
Balance Sheet | ||||||
| Total Assets | 94.62B | 92.34B | 88.47B | 78.52B | 62.77B | 59.20B |
| Cash, Cash Equivalents and Short-Term Investments | 26.52B | 22.31B | 19.89B | 17.58B | 12.72B | 17.90B |
| Total Debt | 18.87B | 17.35B | 15.44B | 13.12B | 4.44B | 2.51B |
| Total Liabilities | 29.76B | 29.67B | 28.18B | 24.05B | 13.84B | 10.11B |
| Stockholders Equity | 64.20B | 62.06B | 59.80B | 54.03B | 48.64B | 48.98B |
Cash Flow | ||||||
| Free Cash Flow | 2.32B | 5.53B | 6.69B | 4.07B | -2.11B | -4.26B |
| Operating Cash Flow | 10.45B | 11.43B | 13.36B | 11.48B | 7.22B | 4.95B |
| Investing Cash Flow | -3.26B | -5.98B | -12.25B | -16.04B | -8.76B | -3.55B |
| Financing Cash Flow | -4.40B | -5.00B | -769.84M | 7.06B | -2.90B | 8.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$143.01B | 11.17 | 14.02% | 3.05% | 12.64% | 2.90% | |
73 Outperform | HK$94.22B | 9.94 | 7.51% | ― | 11.05% | 81.01% | |
64 Neutral | HK$48.04B | 11.39 | 9.46% | 6.39% | -17.69% | -3.38% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | HK$12.00B | 5.27 | 8.00% | 3.55% | 26.36% | -18.67% | |
62 Neutral | HK$2.38B | 17.02 | 9.22% | 8.25% | 56.58% | 1963.38% | |
61 Neutral | HK$91.56B | 24.42 | 5.53% | ― | 12.14% | ― |